Buyout giant Bain Capital has raised $1.9bn for its second life sciences-focused fund targeting pharma and biopharma, medical device and diagnostics deals.
The post Bain Capital continues 2021 fundraising streak with hefty $1.9bn life science vehicle first appeared on AltAssets Private Equity News.
